A BIOMEDICAL COMPANY FOCUSED ON DEVELOPING AN RNA-BASED PLATFORM OF TARGETED THERAPY DELIVERY TO TREAT CANCER
Aptadel Therapeutics is a pre-clinical stage drug development biotech company based on RNA Aptamer technology for the treatment of cancer.
Its Aptamer technology is a delivery tool platform for different therapeutic agents (siRNA, miRNA, chemotherapeutic drugs, small molecules…) that can be used in several indications.
The Company is a spin off from IDIBELL, also co-founded by Fundación Alba. It is based in the Parc Cientific de Barcelona (PCB).